Showing results (81-90 of 668) with videos related to
Sort By:
Pageof 67
Pharmacology, Biochemistry, and Behavior|September 23, 1997
Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonistsA M Deveney, J L WaddingtonEuropean Journal of Pharmacology|October 31, 1980
Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administrationJ L Waddington, S J GambleEuropean Journal of Pharmacology|May 8, 1981
Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatumA J Cross, J L WaddingtonPsychopharmacology|May 5, 1998
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approachJ J Clifford, J L WaddingtonNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonistsJ J Clifford, J L WaddingtonNeuroscience Letters|September 1, 1979
Pharmacology of (+)- and (-)-baclofen: GABA-dependant rotational behaviour and [3H]GABA receptor binding studiesJ L Waddington, A L CrossNaunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 1979
Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor bindingJ L Waddington, A J CrossEuropean Journal of Pharmacology|February 5, 1985
Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramideA G Molloy, J L WaddingtonThe American Journal of Psychiatry|September 1, 1986
An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptomsJ L Waddington, H A YoussefEuropean Journal of Pharmacology|October 8, 1985
The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213A G Molloy, J L WaddingtonPageof 67